Tetratherix (ASX:TTX) YoY EBITDA Growth: 40.30% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:TTX Tetratherix Ltd ASX:TTX
6 GF Score
Price A$6.94
! 5 Warning Signs
View Full Analysis

What is Tetratherix YoY EBITDA Growth?

Tetratherix ASX:TTX +0.29% 6 YoY EBITDA Growth is 40.30% as of Jun. 2026. GuruFocus rates ASX:TTX with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Tetratherix's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 40.30%.

Tetratherix's EBITDA per Share for the six months ended in Jun. 2026 was A$-0.08.

Tetratherix YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Tetratherix's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tetratherix YoY EBITDA Growth Chart

Tetratherix Annual Data
Trend Jun23 Jun24 Jun25 Jun26
YoY EBITDA Growth
0.00 -13.16 -317.44 54.32

Tetratherix Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial 0.00 -15.91 -226.83 -62.75 40.30
ASX:TTX
6GF Score
Tetratherix Ltd ASX:TTX
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tetratherix YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Tetratherix's YoY EBITDA Growth for the fiscal year that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (A: Jun. 2026 )
=(EBITDA per Share (A: Jun. 2026 )-EBITDA per Share (A: Jun. 2025 ))/ | EBITDA per Share (A: Jun. 2025 ) |
=(-0.164--0.359)/ | -0.359 |
=54.32 %

Tetratherix's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(-0.08--0.134)/ | -0.134 |
=40.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 40.30% mean?
Tetratherix (ASX:TTX) has a YoY EBITDA Growth of 40.30% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Tetratherix and its competitors.
Is Tetratherix's YoY EBITDA Growth too high?
Tetratherix's current YoY EBITDA Growth is 40.30%. Overall, Tetratherix has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Tetratherix's YoY EBITDA Growth compare to VRTX and REGN?
Tetratherix's YoY EBITDA Growth of 40.30% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Biotechnology company?
A good YoY EBITDA Growth depends on the Biotechnology industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Tetratherix and its competitors. Tetratherix's current YoY EBITDA Growth is 40.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tetratherix stock overvalued right now?
Tetratherix (ASX:TTX) has a current YoY EBITDA Growth of 40.30%. The current YoY EBITDA Growth is 40.30%. Tetratherix's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Tetratherix (ASX:TTX), the current YoY EBITDA Growth is 40.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tetratherix Business Description

Address 34-36 Ralph Street, Unit 29, Alexandria, Sydney, NSW, AUS, 2015
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
6GF Score

Get the complete analysis for ASX:TTX

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.94
Price